tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Similar Stocks

Compare
161 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
NewAmsterdam Pharma Company
$23.80
$2.58B
13.50%
8 Buy
0 Hold
0 Sell
Strong Buy
Amarin
$0.53
$219.74M
-44.21%
0 Buy
0 Hold
0 Sell
Hold
Madrigal Pharmaceuticals
$331.41
$7.67B
28.76%
14 Buy
0 Hold
1 Sell
Strong Buy
Esperion
$1.69
$313.29M
-31.30%
6 Buy
1 Hold
1 Sell
Moderate Buy
Viking Therapeutics
$29.10
$3.22B
-68.09%
14 Buy
1 Hold
0 Sell
Strong Buy
Akero Therapeutics
$42.12
$3.48B
40.40%
11 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
NAMS
NewAmsterdam Pharma Company
23.80
2.86
13.66%
AMRN
Amarin
0.53
-0.37
-41.11%
MDGL
Madrigal Pharmaceuticals
331.41
71.26
27.39%
ESPR
Esperion
1.69
-0.43
-20.28%
VKTX
Viking Therapeutics
29.10
-34.34
-54.13%
AKRO
Akero Therapeutics
42.12
12.81
43.71%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis